Relationships of , , and Gene Polymorphisms with Gestational Diabetes Mellitus in a Chinese Population
Overview
Biotechnology
General Medicine
Authors
Affiliations
Background: Solute carrier family 2 member 4- (SLC2A4-) retinol binding protein-4- (RBP4-) phosphoenolpyruvate carboxykinase 1 (PCK1)/phosphoinositide 3-kinase (PI3K) is an adipocyte derived "signalling pathway" that may contribute to the pathogenesis of type 2 diabetes mellitus (T2DM). We explored whether single nucleotide polymorphisms (SNPs) of these "signalling pathway" genes are associated with gestational diabetes mellitus (GDM).
Methods: Case-control studies were conducted to compare GDM and control groups. A total of 334 cases and 367 controls were recruited. Seventeen candidate SNPs of the pathway were selected. Chi-square tests, logistic regression, and linear regression were used to estimate the relationships of SNPs with GDM risk and oral glucose tolerance test (OGTT), fasting insulin, and homeostasis model assessment of insulin resistance (HOMA-IR) levels. Model-based multifactor dimensionality reduction was used to estimate the adjusted interactions between genes. Regression and interaction analyses were adjusted by maternal age, prepregnancy BMI, and weekly BMI growth. The Bonferroni correction was applied for multiple comparisons.
Results: rs7091052 was significantly associated with GDM risk. rs5435, rs7091052, rs1042531 and rs2236745, and (coding gene of the PI3K P85 subunit) rs34309 were associated with OGTT, fasting insulin, and HOMA-IR levels in the linear regression analysis. The gene-gene interaction analysis showed that, compared with pregnant women with other genotype combinations, women with rs5435 (CC/CT), rs7091052 (CC), rs1042531 (TT/TG) and rs2236745 (TT), and rs34309 (AA) had lower GDM risk.
Conclusion: , , and genes may be involved in the pathogenesis of GDM.
Zieleniak A, Zurawska-Klis M, Laszcz K, Bulash K, Pacyga D, Cypryk K Int J Mol Sci. 2024; 25(23).
PMID: 39684804 PMC: 11641716. DOI: 10.3390/ijms252313094.
Longitudinal integrative cell-free DNA analysis in gestational diabetes mellitus.
Tang Z, Wang S, Li X, Hu C, Zhai Q, Wang J Cell Rep Med. 2024; 5(8):101660.
PMID: 39059385 PMC: 11384941. DOI: 10.1016/j.xcrm.2024.101660.
Genetic and Epigenetic Factors in Gestational Diabetes Mellitus Pathology.
Ustianowski L, Udzik J, Szostak J, Goracy A, Ustianowska K, Pawlik A Int J Mol Sci. 2023; 24(23).
PMID: 38068941 PMC: 10706782. DOI: 10.3390/ijms242316619.
Functionally Significant Variants in Genes Associated with Abdominal Obesity: A Review.
Bairqdar A, Ivanoshchuk D, Shakhtshneider E J Pers Med. 2023; 13(3).
PMID: 36983642 PMC: 10056771. DOI: 10.3390/jpm13030460.
Current Studies on Molecular Mechanisms of Insulin Resistance.
Pei J, Wang B, Wang D J Diabetes Res. 2023; 2022:1863429.
PMID: 36589630 PMC: 9803571. DOI: 10.1155/2022/1863429.